Immunosuppressive and anti-inflammatory effects of nicotine administered by patch in an animal model

Clinical and Diagnostic Laboratory Immunology

Volumn 11, Issue 3, 2004, Pages 563-568

  Kalra, Roma ^a   Singh, Shashi P ^a   Pena Philippides, Juan C ^a   Langley, Raymond J ^a   Razani Boroujerdi, Seddigheh ^a   Sopori, Mohan L ^a  

^a LOVELACE RESPIRATORY RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CONCANAVALIN A; COTININE; NICOTINE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA1; PROTEIN TYROSINE KINASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BLOOD LEVEL; CALCIUM CELL LEVEL; CALCIUM MOBILIZATION; CHRONIC DRUG ADMINISTRATION; CONTROLLED STUDY; ENZYME ACTIVATION; ERYTHROCYTE; FEVER; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; OSMOTIC MINIPUMP; PRIORITY JOURNAL; RAT; SHEEP; SMOKING; SMOKING CESSATION; SPLEEN CELL; T LYMPHOCYTE; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIBODIES, MONOCLONAL; ANTIBODY FORMATION; BLOTTING, WESTERN; BODY TEMPERATURE; CALCIUM SIGNALING; CELL PROLIFERATION; CONCANAVALIN A; COTININE; ERYTHROCYTES; HEMOLYTIC PLAQUE TECHNIQUE; IMMUNITY; IMMUNITY, CELLULAR; IMMUNOSUPPRESSIVE AGENTS; MALE; NICOTINE; PHOSPHOLIPASE C; PHOSPHOLIPASE C GAMMA; PHOSPHORYLATION; PROTEIN-TYROSINE KINASES; RATS; RATS, INBRED LEW; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SPECIFIC PATHOGEN-FREE ORGANISMS; SPLEEN; T-LYMPHOCYTES; TURPENTINE; VACCINATION;

EID: 2442639095     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/CDLI.11.3.563-568.2004     Document Type: Article

References (48)

1. Arneric, S. P., J. P. Sullivan, M. W. Decker, J. D. Brioni, A. W. Bannon, C. A. Briggs, D. Donnelly-Roberts, R. J. Radek, K. C. Marsh, and J. Kynel. 1995. Potential treatment of Alzheimer disease using cholinergic channel activators (ChCAs) with cognitive enhancement, anxiolytic-like, and cytoprotective properties. Alzheimer Dis. Assoc. Disord. 9(Suppl. 2):50-61.
2. Berridge, M. J. 1993. Cell signalling. A tale of two messengers. Nature 365:388-389.
3. Birtwistle, J., and K. Hall. 1996. Does nicotine have beneficial effects in the treatment of certain diseases? Br. J. Nurs. 5:1195-1202.
4. Clapham, D. E. 1995. Calcium signaling. Cell 80:258-268.
5. a. Committee on Care and Use of Laboratory Animals. 1985. Guide for the care and use of laboratory animals. Institute of Laboratory Animal Resources, Commission on Life Sciences, National Research Council, National Academy Press, Washington, D.C.
6. Cunningham, A. J., and A. Szenberg. 1968. Further improvements in the plaque technique for detecting single antibody-forming cells. Immunology 14:599-600.
7. Davidson, M., M. Epstein, R. Burt, C. Schaefer, G. Whitworth, and A. McDonald. 1998. Efficacy and safety of an over-the-counter transdermal nicotine patch as an aid for smoking cessation. Arch. Fam. Med. 7:569-574.
8. Geng, Y., S. M. Savage, L. J. Johnson, J. C. Seagrave, and M. L. Sopori. 1995. Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Toxicol. Appl. Pharmacol. 135:268-278.
9. Geng, Y., S. M. Savage, S. Razani-Boroujerdi, and M. L. Sopori. 1996. Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J. Immunol. 156:2384-2390.
10. Gershenwald, J. E., Y. M. Fong, T. J. Fahey III, S. E. Calvario, R. Chizzonite, P. L. Kilian, S. F. Lowry, and L. L. Moldawer. 1990. Interleukin 1 receptor blockade attenuates the host inflammatory response. Proc. Natl. Acad. Sci. USA 87:4966-4970.
11. Hasegawa, Y., H. Kaneoka, T. Tanaka, S. Ogahara, T. Matsumae, R. Noda, K. Yoshitake, T. Murata, and S. Naito. 2001. Suppression of experimental membranous glomerulonephritis in rats by an anti-MHC class II antibody. Nephron 88:233-240.
12. Holt, P. G., and D. Keast. 1977. Environmentally induced changes in immunological function: acute and chronic effects of inhalation of tobacco smoke and other atmospheric contaminants in man and experimental animals. Bacteriol. Rev. 41:205-216.
13. James, J. R., and A. Nordberg. 1995. Genetic and environmental aspects of the role of nicotinic receptors in neurodegenerative disorders: emphasis on Alzheimer's disease and Parkinson's disease. Behav. Genet. 25:149-159.
14. Jarvik, M. E. 1991. Beneficial effects of nicotine. Br. J. Addict. 86:571-575.
15. Jolicoeur, D. G., K. P. Richter, J. S. Ahluwalia, M. C. Mosier, and K. Resnicow. 2003. Smoking cessation, smoking reduction, and delayed quitting among smokers given nicotine patches and a self-help pamphlet. Subst. Abuse 24:101-106.
16. Kaira, R., S. P. Singh, S. M. Savage, G. L. Finch, and M. L. Sopori. 2000. Effects of cigarette smoke on the immune response: chronic exposure to cigarette smoke impairs antigen-mediated signaling in T cells and depletes IP3-sensitive calcium stores. J. Pharmacol. Exp. Ther. 293:166-171.
17. Kimura, M., M. Yamashita, M. Kubo, M. Iwashima, C. Shimizu, K. Tokoyoda, J. Chiba, M. Taniguchi, M. Katsumata, and T. Nakayama. 2000. Impaired Ca/calcineurin pathway in in vivo anergized CD4 T cells. Int. Immunol. 12:817-824.
18. Kozak, W., H. Zheng, C. A. Conn, D. Soszynski, L. H. van der Ploeg, and M. J. Kluger. 1995. Thermal and behavioral effects of lipopolysaccharide and influenza in interleukin-1 beta-deficient mice. Am. J. Physiol. 269:R969-R977.
19. Kozak, W., J. J. Klir, C. A. Conn, and M. J. Kluger. 1997. Attenuation of lipopolysaccharide fever in rats by protein kinase C inhibitors. Am. J. Physiol. 273:R873-R879.
20. Mills, C. M., T. J. Peters, and A. Y. Finlay. 1993. Does smoking influence acne? Clin. Exp. Dermatol. 18:100-101.
21. Newhouse, P. A., A. Potter, and E. D. Levin. 1997. Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11:206-228.
22. Nicot, A., P. V. Ratnakar, Y. Ron, C. C. Chen, and S. Elkabes. 2003. Regulation of gene expression in experimental autoimmune encephalomyelitis indicates early neuronal dysfunction. Brain 126:398-412.
23. Nishibe, S., M. Wahl, S. M. T. Hernandez-Sotomayor, N. K. Tonks, S. G. Rhee, and G. Carpenter. 1990. Increase of the catalytic activity of phospholipase C-γ1 by tyrosine phosphorylation. Science 250:1253-1256.
24. Perng, R. P., W. C. Hsieh, Y. M. Chen, C. C. Lu, and S. J. Chiang. 1998. Randomized, double-blind, placebo-controlled study of transdermal nicotine patch for smoking cessation. J. Formos. Med. Assoc. 97:547-551.
25. Prochazka, A. V. 2000. New developments in smoking cessation. Chest 117:169S-175S.
26. Razani-Boroujerdi, S., L. D. Partridge, and M. L. Sopori. 1994. Intracellular calcium signaling induced by thapsigargin in excitable and inexcitable cells. Cell Calcium 16:467-474.
27. Robey, E., and J. P. Allison. 1995. T-cell activation: integration of signals from the antigen receptor and costimulatory molecules. Immunol. Today 16:306-310.
28. Salomon, A. R., K. J. Marcinowski, R. P. Friedland, and M. G. Zagorski. 1996. Nicotine inhibits amyloid formation by the beta-peptide. Biochemistry 35:13568-13578.
29. Saper, C. B. 1998. Neurobiological basis of fever. Ann. N. Y. Acad. Sci. 856:90-94.
30. Silagy, C., D. Mant, G. Fowler, and T. Lancaster. 2000. Nicotine replacement therapy for smoking cessation. Cochrane Database Syst. Rev. 2000(3): CD000146. [Online.]
31. Silverstein, M. D., B. A. Lashner, and S. B. Hanauer. 1994. Cigarette smoking and ulcerative colitis: a case-control study. Mayo Clin. Proc. 69:425-429.
32. Singh, S. P., R. Kalra, P. Puttfarcken, A. Kozak, J. Tesfaigzi, and M. L. Sopori. 2000. Acute and chronic nicotine exposures modulate the immune system through different pathways. Toxicol. Appl. Pharmacol. 164:65-72.
33. Sloan-Lancaster, J., and P. M. Allen. 1996. Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology. Annu. Rev. Immunol. 14:1-27.
34. Sopori, M. L., Y. L. Hurt, S. Cherian, A. M. Kaplan, and T. Diamantstein. 1987. Differential requirement for accessory cells in polyclonal T cell activation. Cell. Immunol. 105:174-186.
35. Sopori, M. L., S. Cherian, R. Chilukuri, and G. M. Shopp. 1989. Cigarette smoke causes inhibition of the immune response to intratracheally administered antigens. Toxicol. Appl. Pharmacol. 97:489-499.
36. Sopori, M. L., N. Goud, and A. M. Kaplan. 1994. Effects of tobacco smoke on the immune system, p. 413-434. In D. Luster, A. Munson, and I. Kimber (ed.), Immunotoxicology and immunopharmacology. Raven Press, New York, N.Y.
37. Sopori, M. L. 1998. Immunosuppressive and anti-inflammatory properties of nicotine, p. 197-209. In S. Americ and J. D. Brioni (ed.), Neuronal nicotinic receptors: pharmacology and therapeutic opportunities. John Wiley & Sons Press, New York, N.Y.
38. Sopori, M. L., W. Kozak, S. M. Savage, Y. Geng, D. Soszynski, M. J. Kluger, E. K. Perryman, and G. E. Snow. 1998. Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology 23:189-204.
39. Sopori, M. L. 2002. Effects of cigarette smoke on the immune system. Nat. Rev. Immunol. 2:372-377.
40. Srivastava, E. D., M. A. Russell, C. Feyerabend, and J. Rhodes. 1990. Effect of ulcerative colitis and smoking on rectal blood flow. Gut 31:1021-1024.
41. Stanislaus, R., A. G. Gilg, A. K. Singh, and I. Singh. 2002. Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by lovastatin. Neurosci. Lett. 333:167-170.
42. Stephan, M., R. H. Straub, T. Breivik, R. Pabst, and S. von Horsten. 2002. Postnatal maternal deprivation aggravates experimental autoimmune encephalomyelitis in adult Lewis rats: reversal by chronic imipramine treatment. Int. J. Dev. Neurosci. 20:125-132.
43. Trauth, J. A., F. J. Seidler, E. C. McCook, and T. A. Slotkin. 1999. Adolescent nicotine exposure causes persistent upregulation of nicotinic cholinergic receptors in rat brain regions. Brain Res. 851:9-19.
44. Wang, H., M. Yu, M. Ochani, C. A. Amella, M. Tanovic, S. Susarla, J. H. Li, H. Wang, H. Yang, L. Ulloa, Y. Al-Abed, C. J. Czura, and K. J. Tracey. 2003. Nicotinic acetylcholine receptor alpha 7 subunit is an essential regulator of inflammation. Nature 421:328-329.
45. Weiss, A., G. Koretzky, R. C. Schatzman, and T. Kadlecek. 1991. Functional activation of the T-cell antigen receptor induces tyrosine phosphorylation of phospholipase C-γ1. Proc. Natl. Acad. Sci. USA 8:5484-5488.
46. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
47. Yu, S., Y. Zhu, Z. Chen, M. Alheim, A. Ljungberg, and J. Zhu. 2002. Initiation and development of experimental autoimmune neuritis in Lewis rats is independent of the cytotoxic capacity of NKR-P1A+ cells. J. Neurosci. Res. 67:823-828.
48. Zou, L. P., N. Abbas, I. Volkmann, I. Nennesmo, M. Levi, B. Wahren, B. Winblad, G. Hedlund, and J. Zhu. 2002. Suppression of experimental autoimmune neuritis by ABR-215062 is associated with altered Th1/Th2 balance and inhibited migration of inflammatory cells into the peripheral nerve tissue. Neuropharmacology 42:731-739.